Accessibility Menu
Mach7 Technologies logo

Mach7 Technologies(ASX) M7T

Market CapA$65.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)-56%
5 Year-72%
1 Year-24%
1 Month-8%
A$0.28
+0.00%
+0.00Today
Mach7 Technologies last closing stock price
MetricPriceDate
Last closeAUD 0.282026-08-13
Mach7 Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%AUD 0.282026-08-06
1 month-8.2%AUD 0.312026-07-14
3 month-3.45%AUD 0.292026-05-15
Year to date-54.47%AUD 0.622025-12-31
1 year-24.32%AUD 0.372025-08-13
3 year-65%AUD 0.802023-08-14
5 year-72.41%AUD 1.022021-08-13
Since inception-55.56%AUD 0.632016-04-11

Mach7 Technologies Financials at a Glance

Market Cap

A$65.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$63.23M

Net Income (TTM)

-A$15.29M

EPS (TTM)

-A$0.04

P/E Ratio

-6.57

Dividend

A$0.00

Beta (Volatility)

0.05 (Low)

Price

A$0.28

Volume

0

Open

A$0.28

Previous Close

A$0.28

Daily Range

A$0.28 - A$0.28

52-Week Range

A$0.25 - A$0.69

Estimated Earnings Date

Sep 1, 2026

M7T News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mach7 Technologies

Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations globally. The company focuses on providing innovative tools that enhance the efficiency and effectiveness of medical imaging processes.

Products and Services
  • eUnity enterprise diagnostic viewer for remote access to medical images
  • Vendor-neutral archive (VNA) for comprehensive data management
  • Workflow applications including teleradiology services and quality control tools
Growth Outlook
  • Recent quarterly revenue of AUD 13.65 million shows potential for recovery
  • Trailing twelve months (TTM) revenue growth indicates increasing market demand
  • Strong cash position with AUD 18.49 million available for strategic investments
Financial Highlights
  • Net income for the latest quarter was AUD -5.75 million, reflecting ongoing investment in growth
  • Current ratio of 2.15 suggests strong liquidity and ability to meet short-term obligations
  • Debt ratio of 0.03 indicates a low level of financial leverage
Mach7 Technologies Limited operates in the healthcare information services sector, providing essential software solutions that facilitate medical imaging and data management. The company's flagship product, the eUnity enterprise diagnostic viewer, allows healthcare professionals to access medical images remotely, enhancing patient care and operational efficiency. The vendor-neutral archive (VNA) further supports healthcare organizations by offering a comprehensive data management solution that is agnostic to specific vendors. The growth outlook for Mach7 Technologies appears promising, with recent quarterly revenue indicating a potential recovery trajectory. The trailing twelve months (TTM) revenue growth reflects an increasing demand for the company's innovative solutions in the healthcare sector. Additionally, the company maintains a strong cash position, which provides the flexibility to invest in strategic initiatives and further enhance its product offerings. Financially, the company reported a net income of AUD -5.75 million for the latest quarter, which underscores the ongoing investments being made to drive growth. The current ratio of 2.15 indicates a robust liquidity position, allowing the company to comfortably meet its short-term obligations. Furthermore, a low debt ratio of 0.03 suggests that the company is not heavily reliant on debt financing, which may appeal to risk-averse investors. Overall, Mach7 Technologies Limited presents an intriguing opportunity for investors interested in the healthcare technology sector, particularly those looking for companies with innovative solutions and a solid growth trajectory.
AI Generated • Jul 20, 2026

Industry

Health Care Technology

CEO

Michael Lampron

Headquarters

South Burlington, VT 05403, US

M7T Financials

Key Financial Metrics (TTM)

Gross Margin

5.17%

Operating Margin

-36.18%

Net Income Margin

-33.94%

Return on Equity

-23.86%

Return on Capital

-18.04%

Return on Assets

-18.66%

Earnings Yield

-15.22%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$65.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

235.01M

Volume

0

Avg. Volume

165.61K

Financials (TTM)

Gross Profit

A$9.81M

Operating Income

-A$10.28M

EBITDA

-A$13.70M

Operating Cash Flow

A$881.18K

Capital Expenditure

-A$874.66K

Free Cash Flow

A$6.52K

Cash & ST Invst.

A$18.49M

Total Debt

A$1.75M

Mach7 Technologies Performance Analysis

Mach7 Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 27,080,145N/A
20232023-06-30AUD 30,049,76611.0%
20242024-06-30AUD 29,112,863-3.1%
20252025-06-30AUD 33,768,19516.0%
Mach7 Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3018.5%
Q22024-12-3112.3%
Q42025-06-30-9.5%
Q22025-12-31-14.9%
Mach7 Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.02N/A
20232023-06-30AUD -0.00-74.9%
20242024-06-30AUD -0.03652.3%
20252025-06-30AUD -0.03-22.1%
Mach7 Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3028.5%
Q22024-12-3144.2%
Q42025-06-30-135.1%
Q22025-12-31-35.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$13.65M

+2.4%

Gross Profit

-A$2.43M

+5.9%

Gross Margin

-17.78%

N/A

Market Cap

A$65.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$394.03K

N/A

Employees

167

N/A

Net Income

-A$5.75M

-24.0%

EBITDA

-A$2.27M

-22.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$18.49M

-18.7%

Total Debt

A$1.75M

+63.4%

Accounts Receivable

A$5.25M

-34.6%

Inventory

A$0.00

N/A

Long Term Debt

A$1.52M

+77.8%

Short Term Debt

A$226.07K

-47.1%

Return on Assets

-18.66%

N/A

Return on Invested Capital

-25.50%

N/A

Free Cash Flow

-A$3.67M

-1329.3%

Operating Cash Flow

-A$3.63M

-1781.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CYC.AXCyclopharm Limited
A$0.52-2.80%
SHG.AXSingular Health Group Ltd
A$0.19-2.63%
ATX.AXAmplia Therapeutics Limited
A$0.15+3.57%
CMP.AXCompumedics Limited
A$0.23+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.56+0.02%
CDECoeur Mining
$18.45-0.02%
TAT&T
$24.58+0.01%
SMRNuScale Power
$9.85+0.03%

Questions About M7T

What is the current price of Mach7 Technologies?

Mach7 Technologies is trading at A$0.28 per share.

What is the 52-week range for Mach7 Technologies?

Over the past 52 weeks, Mach7 Technologies has traded between A$0.25 and A$0.69.

How much debt does Mach7 Technologies have?

As of the most recent reporting period, Mach7 Technologies reported total debt of A$1.12M.

How much cash does Mach7 Technologies have on hand?

Mach7 Technologies reported A$23.07M in cash and cash equivalents in its most recent financial results.

What is Mach7 Technologies’s dividend yield?

Mach7 Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.